These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37106126)

  • 1. TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background.
    Guijarro MV; Nawab A; Dib P; Burkett S; Luo X; Feely M; Nasri E; Seifert RP; Kaye FJ; Zajac-Kaye M
    Oncogene; 2023 Jun; 42(23):1926-1939. PubMed ID: 37106126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice.
    You MJ; Castrillon DH; Bastian BC; O'Hagan RC; Bosenberg MW; Parsons R; Chin L; DePinho RA
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1455-60. PubMed ID: 11818530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.
    Bardeesy N; Aguirre AJ; Chu GC; Cheng KH; Lopez LV; Hezel AF; Feng B; Brennan C; Weissleder R; Mahmood U; Hanahan D; Redston MS; Chin L; Depinho RA
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5947-52. PubMed ID: 16585505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.
    Randle DH; Zindy F; Sherr CJ; Roussel MF
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9654-9. PubMed ID: 11481442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the Cockayne syndrome B gene impairs spontaneous tumorigenesis in cancer-predisposed Ink4a/ARF knockout mice.
    Lu Y; Lian H; Sharma P; Schreiber-Agus N; Russell RG; Chin L; van der Horst GT; Bregman DB
    Mol Cell Biol; 2001 Mar; 21(5):1810-8. PubMed ID: 11238917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma.
    Ko JY; Lee TC; Hsiao CF; Lin GL; Yen SH; Chen KY; Hsiung CA; Chen PJ; Hsu MM; Jou YS
    Cancer; 2002 Apr; 94(7):1987-96. PubMed ID: 11932901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss.
    Debies MT; Gestl SA; Mathers JL; Mikse OR; Leonard TL; Moody SE; Chodosh LA; Cardiff RD; Gunther EJ
    J Clin Invest; 2008 Jan; 118(1):51-63. PubMed ID: 18060046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
    Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
    Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
    Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia.
    Bardeesy N; Morgan J; Sinha M; Signoretti S; Srivastava S; Loda M; Merlino G; DePinho RA
    Mol Cell Biol; 2002 Jan; 22(2):635-43. PubMed ID: 11756558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
    Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
    Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame.
    Yang J; Luan J; Yu Y; Li C; DePinho RA; Chin L; Richmond A
    Cancer Res; 2001 Nov; 61(22):8150-7. PubMed ID: 11719444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
    Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
    Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and p16
    Azzopardi S; Pang S; Klimstra DS; Du YN
    Neoplasia; 2016 Oct; 18(10):610-617. PubMed ID: 27664376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16(Ink4a) interferes with Abelson virus transformation by enhancing apoptosis.
    Sachs Z; Sharpless NE; DePinho RA; Rosenberg N
    J Virol; 2004 Apr; 78(7):3304-11. PubMed ID: 15016851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice.
    Shank-Calvo JA; Draheim K; Bhasin M; Kelliher MA
    Oncogene; 2006 May; 25(21):3023-31. PubMed ID: 16407836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis.
    Altomare DA; Menges CW; Xu J; Pei J; Zhang L; Tadevosyan A; Neumann-Domer E; Liu Z; Carbone M; Chudoba I; Klein-Szanto AJ; Testa JR
    PLoS One; 2011 Apr; 6(4):e18828. PubMed ID: 21526190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.